HOLOXICA secures €1.28M funding from EU to build disruptive holographic video display for medical scanners

[vc_row][vc_column width=”1/2″][vc_column_text]

Funding can lead to significant ‘step change’ in clinical CT, ultrasound and MRI scanning machines

Edinburgh, Scotland – Monday 8th February 2016; Holoxica, the specialist holographic 3D visualisation company, has secured €1.28million from the European Commission’s Horizon2020 SME Instrument, the largest ever EU Research and Innovation Funding Programme. The fund will assist the development of pioneering medical imaging technology using motion holographic video displays for faster interpretation of 3D scan images which will lead to better quality surgical procedures.

The EC’s Horizon2020 SME instrument – a €740M programme aimed to assist job creation and growth for SME businesses involved in cutting edge research and innovation – is keenly contested with 1000s of SMEs submitting applications to the fund from across the EU. Only the ‘best of the best’ proposals are offered funding. To date, only four companies in Scotland have received this award.

Holoxica will use the funding to build a prototype holographic video display for use in CT, MRI and Ultrasound volumetric scanning and as Dr Javid Khan, founder and CEO of Holoxica, explains, the potential for this ground-breaking disruptive technology will be keenly anticipated by clinicians and surgeons and tap into a market for medical imaging 3D display which is set to be worth an estimated $4.3bn by 2020.

“The concept behind the innovation is simple: 3D images should be viewed in 3D easily and comfortably. Current solutions to viewing 3D images using glasses or optical tricks are too clumsy and awkward, leading to problems like motion sickness and disorientation. Holographic technology offers a solution to this problem.

“We see holographic video displays completely transforming the field of medical imaging. In recent years, there has certainly been improvements in the clarity and detail of datasets produced by Ultrasound, CT, PET and MRI scanners, but whilst these machines generate 3D volumetric imagery as a series of 2D ‘slices’ scanned through the body using radiation, we can present the scans as wholly 3D images via holographic volume displays.

The display essentially performs the inverse operation and converts radiation into a photonic representation, showing the 2D ‘slices’ as a series of ‘light sheets’ suspended in free space.”

[/vc_column_text][/vc_column][vc_column width=”1/2”][vc_column_text]When built, the holographic video display will be tested in three pilot scenarios for medical teacher/training; diagnostics, review and monitoring of conditions and also for live surgery. Holoxica will carry out initial testing of the holographic video display prototype at Kings College, London; Guys and St Thomas’s Hospital, London and the Clinical Research Imaging Centre at the University of Edinburgh. Siemens Healthcare, the largest provider of medical equipment in Europe, is keen to trial the technology once it is ready for clinical use.

Holoxica is seeking further investment from Angels and Venture Capital funds to transform the prototype into a product that can be used in a clinical setting. The investment is required for further integration, engineering, user-interface software and full trials. Holoxica will shortly move site from Edinburgh University to CodeBase, the UK’s largest technology incubator. This will enable the company to expand and grow.

Holoxica’s R & D has revealed that holographic video display technology is capable of producing excellent results with large, bright images effectively ‘floating’ in mid-air without the need for cumbersome 3D glasses. The breakthrough innovation will meet an urgent demand from medical professionals for a 3D visualisation solution that can match the performance of scanning devices.

Horizon2020 funds researchers and innovators at the cutting edge of their research disciplines, working on the latest breakthroughs in technology. It supports projects across the cycle from research to innovation, using a range of financial instruments to facilitate their exploitation and access to markets.

Caroline Gray-Stephens of Scottish Enterprise’s Enterprise Europe Network team, said;

“Holoxica’s success is remarkable given the fierce competition from businesses across Europe to access this funding, it’s great to see a Scottish company succeeding against some of the top European innovators.

“However, this is about more than just funding – Holoxica will also receive free business coaching as part of the package of support, and the Enterprise Europe Network team will be on hand to support the company as they commercialise their pioneering medical imaging technology.”


About Holoxica

holoxica logo

mri[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/3″][vc_column_text]About Holoxica

Holoxica is an award-winning company specializing in 3D holographic technologies including digital holograms and holographic video displays. Digital holograms are aimed at high-end professional applications including medical imaging, scientific analysis, engineering design and architecture. Holoxica has also pioneered a series of patented dynamically changeable holographic displays over the past few years. The displays have live 3D images floating in mid-air, allowing you to ‘touch’ icons in space and to do things like draw in mid-air. The latest, third generation display, is aimed at medical imaging applications for CT, MRI and Ultrasound scanners.

[/vc_column_text][/vc_column][vc_column width=”1/3″][vc_column_text]About Horizon2020

Horizon 2020 is the EU’s flagship research and innovation programme, running from 2014 to 2020 with an estimated budget of €80 billion. The programme is structured around three pillars. The first pillar, “Excellent Science”, focuses on basic science, funding future and emerging technologies, researcher mobility) and large European research infrastructure projects. The second pillar is “Industrial Leadership” aimed at industrial technologies: ICT, Nanotechnologies, Space, Biotechnology and Advanced Materials manufacturing and processing. The third pillar funds “Solutions to Social and Economic Problems” in health, energy, transport, food, security and climate change. The SME instrument was specifically designed to enable high tech SMEs with innovative ideas to enter the market with disruptive new products.

[/vc_column_text][/vc_column][vc_column width=”1/3″][vc_column_text]About Scottish Enterprise

Scottish Enterprise is Scotland’s main economic development agency and aims to deliver a significant, lasting effect on the Scottish economy. Our role is to help identify and exploit the best opportunities for economic growth. We support ambitious Scottish companies to compete within the global marketplace and help build Scotland’s globally competitive sectors. We also work with a range of partners in the public and private sectors to attract new investment to Scotland and to help create a world-class business environment.

Follow us on Twitter at http://twitter.com/scotent
Follow us on Facebook at http://www.facebook.com/scottishenterprise[/vc_column_text][/vc_column][/vc_row]